deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT04543812

PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

A Phase 3 Study of PBF-1681 Comprising a 16-week, Placebo-controlled, Double-blind Randomized Period and an 8-week, Open-label Extension Period for the Treatment of Iron Deficiency Anemia in Patients With Non-Dialysis Dependent CKD

Sponsor: Panion & BF Biotech Inc.

Conditions Anemia of Chronic Kidney Disease
Interventions Ferric citrate Placebo
Updated 10 times since 2020 Last updated: Jun 24, 2025 Started: Oct 14, 2020 Primary completion: Oct 28, 2022 Completion: Dec 16, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Anemia of Chronic Kidney Disease and is currently completed. Panion & BF Biotech Inc. leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotRecruiting~Apr 2021 – ~Apr 2022 · 12 months · monthly snapshotRecruiting~Apr 2022 – ~Apr 2023 · 12 months · monthly snapshotRecruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotCompleted~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshotCompleted~Sep 2025 – ~Dec 2025 · 3 months · monthly snapshotCompleted~Dec 2025 – present · 7 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Dec 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2025 — Dec 2025 [monthly]

    Completed PHASE3

  3. Jul 2025 — Sep 2025 [monthly]

    Completed PHASE3

  4. Sep 2024 — Jul 2025 [monthly]

    Completed PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

▶ Show 5 earlier versions

  1. Apr 2023 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  2. Apr 2022 — Apr 2023 [monthly]

    Recruiting PHASE3

  3. Apr 2021 — Apr 2022 [monthly]

    Recruiting PHASE3

  4. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  5. Oct 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Panion & BF Biotech Inc.
Data source: Panion & BF Biotech Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations